Merit Medical Systems

Traded on the St. Petersburg Stock Exchange
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy.
Merit Medical Systems stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Merit Medical Systems balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Merit Medical Systems cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Merit Medical Systems multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Merit Medical Systems profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Merit Medical Systems assets
Merit Medical Systems cash flows

Merit Medical Systems shares

TickerNameTypeNominal valueISINPrice
MMSI:USMerit Medical Systems, Inc.Common share-US5898891040$72.31
Merit Medical Systems news
28.04.2022
Net income of Merit Medical Systems under GAAP for 3 months of 2022 was $10.545 million, down 3.8% from $10.958 million in the previous year. Revenue increased 10.6% to $275.415 million from $248.913 million a year earlier.
11.04.2022
FDA has included Embosphere microspheres in the Breakthrough Device Program. They are designed to reduce knee inflammation caused by osteoarthritis by embolizing the popliteal artery. As part of the program, the office will provide priority review, rapid communication regarding device development and clinical trials.
25.02.2022
Merit Medical Systems' GAAP net income for 2021 was $48.454 million, compared to a loss of $9.843 million in the previous year. Revenue increased 11.5% to $1.075 billion from $0.964 billion a year earlier.
Source: {source} pictogram sec.gov
29.10.2021
Merit Medical Systems' GAAP net income for 9M 2021 was $27.841 million, compared to a loss of $25.221 million in the previous year. Revenue increased 12.8% to $796.259 million from $705.871 million a year earlier.
General information
Company nameMerit Medical Systems
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address1600 WEST MERIT PARK WAY SOUTH JORDAN UT 84095 8012531600
Mailing address1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095
Websitewww.merit.com
Information disclosurewww.sec.gov